TY - JOUR
T1 - Seizure- or Epilepsy-Related Emergency Department Visits Before and During the COVID-19 Pandemic - United States, 2019-2021
AU - Sapkota, Sanjeeb
AU - Caruso, Elise
AU - Kobau, Rosemarie
AU - Radhakrishnan, Lakshmi
AU - Jobst, Barbara
AU - DeVies, Jourdan
AU - Tian, Niu
AU - Hogan, R. Edward
AU - Zack, Matthew M.
AU - Pastula, Daniel M.
N1 - Funding Information:
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. R. Edward Hogan reports institutional support for clinical trials from Otsuka Pharmaceutical Development, Cerevel Therapeutics, and Biogen, Inc. Barbara Jobst reports grants from National Institutes of Health, U.S. Department of Defense, Harvard Pilgrim, Inc, and Neuropace, Inc. No other potential conflicts of interest were disclosed.
Publisher Copyright:
© 2022 Department of Health and Human Services. All rights reserved.
PY - 2022/5/27
Y1 - 2022/5/27
N2 - In this study of trends in seizure-related ED visits during the COVID-19 pandemic, seizure-related ED visits during the initial COVID-19 waves declined among all age groups, especially among children aged 0-9 years. These findings are consistent with several other studies (6-8). In one analysis of U.S. ED visits during January 2019-May 2020, the number of weekly all-cause ED visits declined abruptly during March 29-April 25, 2020, along with a decline in ED visits among children aged 0-9 years attributable to common conditions, including influenza, otitis media, upper respiratory conditions, asthma, viral infection, respiratory symptoms, and fever (6). International studies have described a reduction in seizure-related ED visits among children during the COVID-19 pandemic, with one study reporting a notable decline in febrile seizure-related ED visits among children aged 0-6 years (7,8).
AB - In this study of trends in seizure-related ED visits during the COVID-19 pandemic, seizure-related ED visits during the initial COVID-19 waves declined among all age groups, especially among children aged 0-9 years. These findings are consistent with several other studies (6-8). In one analysis of U.S. ED visits during January 2019-May 2020, the number of weekly all-cause ED visits declined abruptly during March 29-April 25, 2020, along with a decline in ED visits among children aged 0-9 years attributable to common conditions, including influenza, otitis media, upper respiratory conditions, asthma, viral infection, respiratory symptoms, and fever (6). International studies have described a reduction in seizure-related ED visits among children during the COVID-19 pandemic, with one study reporting a notable decline in febrile seizure-related ED visits among children aged 0-6 years (7,8).
UR - http://www.scopus.com/inward/record.url?scp=85130840178&partnerID=8YFLogxK
U2 - 10.15585/MMWR.MM7121A4
DO - 10.15585/MMWR.MM7121A4
M3 - Article
C2 - 35617146
AN - SCOPUS:85130840178
SN - 0149-2195
VL - 71
SP - 703
EP - 708
JO - Morbidity and Mortality Weekly Report
JF - Morbidity and Mortality Weekly Report
IS - 21
ER -